These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16612158)

  • 21. Prognostic impact of orotate phosphoribosyl transferase activity in resectable colorectal cancers treated by 5-fluorouracil-based adjuvant chemotherapy.
    Ochiai T; Nishimura K; Noguchi H; Kitajima M; Tsuruoka Y; Takahashi Y; Tsukada A; Watanabe E; Nagaoka I; Futagawa S
    J Surg Oncol; 2006 Jul; 94(1):45-50. PubMed ID: 16788943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H; Iinuma H; Watanabe T
    Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of anti-orotate phosphoribosyltransferase antibody and its application to immunochemical detection in human tumor cells.
    Sakamoto K; Sugimoto Y; Miyadera K; Oka T; Fukushima M
    Int J Mol Med; 2005 Aug; 16(2):245-9. PubMed ID: 16012756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of 5-fluorouracil-related enzyme activities in predicting sensitivity to 5-fluorouracil in bladder carcinoma.
    Furuse H; Hirano Y; Harada M; Ming LH; Aoki T; Kurita Y; Mugiya S; Ushiyama T; Ozono S
    Anticancer Res; 2009 Apr; 29(4):1001-8. PubMed ID: 19414338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orotate phosphoribosyl transferase mRNA expression in oral squamous cell carcinoma and its relationship with the dihydropyrimidine dehydrogenase expression and the clinical effect of 5-fluorouracil.
    Yoshitomi I; Kawasaki G; Yanamoto S; Mizuno A
    Oral Oncol; 2006 Oct; 42(9):880-7. PubMed ID: 16757204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression of 5-fluorouracil metabolic enzymes in primary gastric cancer: correlation with drug sensitivity against 5-fluorouracil.
    Kodera Y; Ito S; Fujiwara M; Mochizuki Y; Nakayama G; Ohashi N; Koike M; Yamamura Y; Nakao A
    Cancer Lett; 2007 Jul; 252(2):307-13. PubMed ID: 17303323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlation between clinicopathological factors and enzymatic activity of orotate phosphoribosyl transferase (OPRT), dihydropyrimidine dehydrogenase (DPD) in esophageal cancer].
    Takemura M; Yoshida K; Morimura K; Osugi H; Lee S; Kishida S
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1283-6. PubMed ID: 20647710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.
    Kinoshita M; Kodera Y; Hibi K; Nakayama G; Inoue T; Ohashi N; Ito Y; Koike M; Fujiwara M; Nakao A
    Anticancer Res; 2007; 27(2):851-6. PubMed ID: 17465211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preparation of anti-OPRT antibody for immunochemical detection].
    Sakamoto K; Sugimoto Y; Miyadera K; Oka T; Fukushima M
    Gan To Kagaku Ryoho; 2005 May; 32(5):653-8. PubMed ID: 15918566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prediction of sensitivity to 5-fluorouracil (5-fu) by metabolic and target enzyme activities in colon cancer].
    Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Ohkawa K; Kudoh H; Koizumi M; Yoshioka M; Shinji S; Yamashita K; Tajiri T
    Gan To Kagaku Ryoho; 2006 Nov; 33(11):1603-9. PubMed ID: 17108726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of orotate phosphoribosyltransferase activity in renal cell carcinoma.
    Mizutani Y; Wada H; Yoshida O; Fukushima M; Nakanishi H; Miki T
    J Urol; 2004 Feb; 171(2 Pt 1):605-10. PubMed ID: 14713770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orotate phosphoribosyltransferase expression level in tumors is a potential determinant of the efficacy of 5-fluorouracil.
    Sakamoto E; Nagase H; Kobunai T; Oie S; Oka T; Fukushima M; Oka T
    Biochem Biophys Res Commun; 2007 Nov; 363(1):216-22. PubMed ID: 17854773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High orotate phosphoribosyltransferase gene expression predicts complete response to chemoradiotherapy in patients with squamous cell carcinoma of the esophagus.
    Kajiwara T; Nishina T; Hyodo I; Moriwaki T; Endo S; Nasu J; Hori S; Matsuura B; Hiasa Y; Onji M
    Oncology; 2009; 76(5):342-9. PubMed ID: 19307741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of orotate phosphoribosyltransferase in colorectal carcinoma: an immunohistochemical analysis in several components of neoplastic lesions.
    Sanada Y; Yoshida K; Hihara J; Okada M
    Oncol Rep; 2008 Nov; 20(5):1005-11. PubMed ID: 18949394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orotate phosphoribosyltransferase gene polymorphism predicts toxicity in patients treated with bolus 5-fluorouracil regimen.
    Ichikawa W; Takahashi T; Suto K; Sasaki Y; Hirayama R
    Clin Cancer Res; 2006 Jul; 12(13):3928-34. PubMed ID: 16818689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of combined administration of DPD-inhibitory oral fluoropyrimidine, S-1, plus paclitaxel on gene expressions of fluoropyrimidine metabolism-related enzymes in human gastric xenografts.
    Sakurai Y; Yoshida I; Kamoshida S; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
    Ann Surg Oncol; 2008 Aug; 15(8):2301-9. PubMed ID: 18506536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Correlation between clinical pathologic factors and enzymatic activity of orotate Phosphoribosyl transferase (OPRT), Dihydropyrimidine dehydrogenase (DPD) and Thymidylate synthase (TS) in colorectal cancer].
    Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Kanazawa Y; Shirakawa T; Ohkawa K; Koizumi M; Ohaki Y; Yamashita K; Tajiri T
    Gan To Kagaku Ryoho; 2006 Jun; 33(6):789-93. PubMed ID: 16770098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of orotate phosphoribosyl transferase in hormone-refractory prostate cancer.
    Tanaka T; Kawashima H; Matsumura K; Yamashita-Hosono T; Yoshimura R; Kuratsukuri K; Harimoto K; Nakatani T
    Oncol Rep; 2009 Jan; 21(1):33-7. PubMed ID: 19082440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of orotate phosphoribosyl transferase in human pancreatic cancer: implication for the efficacy of uracil and tegafur-based adjuvant chemotherapy.
    Nio Y; Toga T; Maruyama R; Fukushima M
    Oncol Rep; 2007 Jul; 18(1):59-64. PubMed ID: 17549346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.